Andrew Bond

Andrew Bond is a seasoned professional with extensive experience in pharmacovigilance and quality management, currently serving as the Director of Safety Alliance Management at CSL since 2003. In this role, Andrew leads the strategic direction for global pharmacovigilance, ensuring compliance and efficient partner mechanisms in patient safety. Andrew has held various prominent positions, including Associate Director for Pharmacovigilance Agreements, where leadership in pharmacovigilance compliance and stakeholder engagement was prioritized. Throughout Andrew's career, responsibilities have spanned quality management systems, supplier audits, and regulatory compliance across multiple regions, alongside contributions as a professional speaker on global pharmacovigilance topics. Andrew's academic credentials include a Bachelor of Science from Deakin University and additional certifications in corporate management and frontline management.